Guidance on consent for Systemic Anti-Cancer Therapy (SACT), plus new regimen-specific consent forms
The National Chemotherapy Board and Cancer Research UK are pleased to launch the Guidance on the consent for SACT and national SACT regimen-specific consent forms. The aim of the guidance and forms is to support clinicians to ensure that patients receiving SACT are fully informed when consenting to treatment.
The guidance document and consent forms can be accessed and downloaded from the Cancer Research UK website
The guidance document encompasses:
- Background to consent for SACT
- National Chemotherapy Board recommendations and the national regimen-specific consent forms
- Guidance for the introduction of the national regimen-specific consent forms by individual chemotherapy providers, e.g. gaining approval from your Trust governance/consent committees
- Guidance for the process of consent for SACT
- Recommendations for the audit of consent procedures
The consent forms for breast cancer SACT regimens are available to download now and forms for other tumour sites will be published throughout the year. The consent forms are being produced by Guy’s and St. Thomas’ NHS Foundation Trust in collaboration with Cancer Research UK. Systems are established to ensure that the forms are regularly reviewed and updated.
We hope that you will find this guidance and the forms useful in ensuring that patients are fully informed when consenting to treatment with SACT in your Trust.
Dr Janine Mansi, Consultant Medical Oncologist, Guy’s and St. Thomas’ NHS Foundation Trust and National Chemotherapy Board
Rena Chauhan, Oncology Pharmacist – CRUK Information Lead, Guy’s and St. Thomas’ NHS Foundation Trust
Prof. Finbarr Cotter, Consultant Haemato-Oncologist, Barts Health NHS Trust, and Chair, National Chemotherapy Board
Sarah Woolnough, Executive Director (Policy and Information), Cancer Research UK